Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,276.00    20.00 (1.59%)
Bid:
1,284.00
Ask:
1,292.00
Spread: 8.00 (0.623%)
Market Cap: £584.74m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

25 Jul 2016 07:00

RNS Number : 0496F
Cohort PLC
22 July 2016
 

25 July 2016

 

Cohort plc

("Cohort" or "the Group")

 

Contract Win

MCL awarded Airborne Tactical Communications Support Contract

Cohort, the independent technology group, today announces that its subsidiary Marlborough Communications Ltd (MCL), has been awarded the UK MOD Airborne Tactical Communications Support Contract.

The contract, valued at up to £7.7m, is to provide support to certain specialist equipment and includes options covering additional development activities. The duration of the contract will be between two and six years, with a minimum value of around £0.9m, depending on the options chosen by the customer. MCL will be supported by its partner Serbus Ltd in the delivery of the contract.

Andrew Thomis, Chief Executive of Cohort plc said:

"This is another excellent win for MCL demonstrating its extremely strong capability in this specialist area. After many years successfully delivering land based tactical communications, we are pleased to have built on this experience enabling this, our first win in the tactical airborne environment.

"This adds further visibility to our order book, which underpins a significant proportion of revenues for Cohort's current financial year."

Ends

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

 

Investec Bank plc

020 7597 5970

Keith Anderson / Daniel Adams

 

MHP Communications Limited

020 3128 8100

Reg Hoare / Jamie Ricketts / Ollie Hoare

 

 

NOTES TO EDITORS

Cohort plc (www.cohortplc.com) is the parent company for five innovative, agile and responsive businesses working primarily for defence, wider government and industry clients. 

· EID (www.eid.pt) - a Portugal based supplier of advanced communications products and systems for the global defence market. EID has been part of the Group since June 2016.

 

· MASS (www.mass.co.uk) - a specialist defence and technology business, focused mainly on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006.

· MCL (www.marlboroughcomms.com) - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014.

 

· SCS (www.scs-ltd.co.uk) - a defence consultancy, combining technical expertise with armed forces experience and domain knowledge. Owned by Cohort since flotation in March 2006. 

 

· SEA (www.sea.co.uk) - an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007. 

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 800 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey, Scotland and Portugal.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTAKBDBABKDDOB
Date   Source Headline
16th Jul 20257:00 amRNSFinal Results
11th Jul 20259:00 amRNS-RInvestor Presentation
11th Jul 20257:00 amRNSNotice of Results
9th Jul 202512:11 pmRNSHolding(s) in Company
1st Jul 202511:00 amRNSTotal Voting Rights
29th May 20257:00 amRNSFull Year Trading Update
12th May 20253:59 pmRNSBlock Listing Application
6th May 20252:00 pmRNS-RContract Win (Replacement)
1st May 20259:00 amRNS-RContract win
1st May 20257:00 amRNSTotal Voting Rights
24th Apr 202512:12 pmRNSDirector/PDMR Shareholding
9th Apr 20253:05 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:41 amRNSBlock Listing Six Monthly Return
1st Apr 20259:58 amRNSTotal Voting Rights
31st Mar 202512:53 pmRNSDirector/PDMR Shareholding
3rd Mar 202512:34 pmRNSTotal Voting Rights
24th Feb 20252:57 pmRNSBlock Listing Six Monthly Return
21st Feb 20252:18 pmRNSDirector/PDMR Shareholding
12th Feb 202511:00 amRNS-RInvestor Presentation via Investor Meet Company
12th Feb 20257:00 amRNSMASS wins extension for JCAST training contract
10th Feb 20257:00 amRNS-RCohort presentation at Shares Spotlight Event
5th Feb 20257:00 amRNS-RInvestor Presentation via Engage Investor
3rd Feb 20255:00 pmRNSTotal Voting Rights
31st Jan 20257:00 amRNSCompletion of EM Solutions Acquisition
24th Jan 20257:00 amRNS-RInvestor Presentation
20th Jan 20257:30 amRNSCompletion date of EM Solutions Acquisition
14th Jan 20257:00 amRNSInterim Report 2024
9th Jan 20257:00 amRNSContract Win
6th Jan 202511:25 amRNSHolding(s) in Company
2nd Jan 20254:44 pmRNSTotal Voting Rights
24th Dec 20248:30 amRNSREVISED COMPLETION OF ACQUISITION
16th Dec 20249:52 amRNSHolding(s) in Company
11th Dec 20242:00 pmRNSHalf Year Results (Replacement)
11th Dec 20247:00 amRNSHalf Year Results
2nd Dec 20242:45 pmRNSTotal Voting Rights
28th Nov 202410:00 amRNSNotice of Half Year Results
21st Nov 202411:26 amRNSResult of the Placing
21st Nov 202411:17 amRNSResult of the Retail Offer
21st Nov 20247:01 amRNSProposed Retail Offer to raise up to £1 million
21st Nov 20247:00 amRNSProposed Placing to raise £40 million
21st Nov 20247:00 amRNSAcquisition of EM Solutions
12th Nov 20249:33 amRNSHolding(s) in Company
4th Nov 20245:42 pmRNSHolding(s) in Company
1st Nov 20245:06 pmRNSTotal Voting Rights
21st Oct 202412:18 pmRNSDirector/PDMR Shareholding
4th Oct 20243:21 pmRNSDirector/PDMR Shareholding
2nd Oct 202411:22 amRNSBlock Listing Six Monthly Return
1st Oct 202411:19 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSAGM Statement
20th Sep 202410:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.